Siilo, Europe's largest messaging network for health and care professionals, is offering health and care professionals free access to its organisational crisis management functionality in response to the COVID-19 outbreak.

Allscripts (NASDAQ: MDRX) is taking several steps to further its commitment to help fight the global spread of COVID-19. The company is working closely with health agencies and governments around the world to keep abreast of changes and partnering with clients to share and enable their Allscripts solutions to help combat the spread of the virus and manage their patients.

Orion Health is applying its resources, technology and experience to offer support to its customers, as healthcare organisations globally face exceptional challenges from the COVID-19 outbreak.

The company is making available its comprehensive screening and remote monitoring software to help manage the care of patients.

Preventicus is proud to announce that the company continues to grow by bringing its unique, comprehensive care management programs for prevention of strokes and cardiovascular events to new international markets. By appointing Ljubisav Matejevic as Chief Sales and Marketing Officer and Member of the Executive Board, Preventicus strengthens its management team as well as its international focus.

Siemens Healthineers announces market introduction of the teamplay digital health platform. With the teamplay digital health platform Siemens Healthineers paves the way for healthcare providers' digital transformation - facilitating easy access to solutions for operational, clinical & shared decision support.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the HealthSuite System of Engagement, an integrated, modular set of standards-based capabilities that support the development of digital health propositions, including new capabilities for cloud-based managed AI workflow and DICOM interoperability.

AI-Pathway Companion Prostate Cancer(2), a digital companion from Siemens Healthineers to support clinical decision-making, has recently received the CE mark for use in the clinical pathway of prostate cancer, the second most common cancer (after lung cancer) affecting males worldwide.(3)